Jen Kates, Senior Vice President and Director of KFF’s Global Health & HIV Policy program presented “The End of the Public Health Emergency Declaration for COVID-19,” at the 2023 Preparedness Summit on April 24.
Rural hospitals fared worse financially in states that have not expanded their Medicaid programs under the Affordable Care Act than in states that expanded Medicaid, a new KFF analysis finds. Nearly one third of all rural hospitals nationally are in th…
This data note examines rural hospitals’ operating margins in recent years. After seeing higher margins early in the pandemic, likely due to government relief funds, rural hospitals now face renewed challenges, especially in states that have not expand…
In this commentary for Barron’s, KFF’s Cynthia Cox and Jennifer Kates explore what will happen with costs to COVID-19 vaccines for people with and without insurance once the relevant public health emergency ends on May 11.
This slideshow examines trends in U.S. health spending over time, including the share of household budgets devoted to health expenses and comparisons of out-of-pocket expenditures to money spent on insurance through 2021.
On Jan. 20, 2023, the Biden Administration announced it will end the public health emergency (and national emergency) declarations on May 11, 2023. This policy watch provides an overview of how health care coverage and access will and won’t change when…
This analysis of 2020 claims data finds that as telehealth use surged as the COVID-19 pandemic hit, the shift toward virtual physician and mental health care did not materially affect how much insurers paid for each patient encounter.
If the federal government runs out of money to purchase COVID-19 vaccines, the per-dose price likely would skyrocket and could increase spending on vaccines by billions of dollars a year, a new KFF analysis finds. To date, the federal government has sp…
This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for …